Profile data is unavailable for this security.
About the company
Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through three business segments: BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including medication delivery solutions, medication management solutions, diabetes care and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
- Revenue in USD (TTM)20.25bn
- Net income in USD2.00bn
- LocationBecton Dickinson and Co1 Becton DrFRANKLIN LAKES 07417-1815United StatesUSA
- Phone+1 (201) 847-6800
Mergers & acquisitions
|Acquired company||Deal status||Date||Date /|
|BDX:NYQ since |
|Scanwell Health Inc||Deal completed||21 Dec 2021||21 Dec 2021Deal completed||4.84%||--|
|Tissuemed Ltd||Deal completed||09 Dec 2021||09 Dec 2021Deal completed||7.38%||--|
|Venclose Inc||Deal completed||02 Dec 2021||02 Dec 2021Deal completed||9.50%||--|
|Tepha Inc||Deal completed||27 Jul 2021||27 Jul 2021Deal completed||6.09%||--|
|Velano Vascular Inc||Deal completed||20 Jul 2021||20 Jul 2021Deal completed||7.03%||--|